Happy New Year 2025 From all of us at Cromos Pharma, we wish you love, happiness, and endless joy in the New Year!  May 2025 bring peace, success, and all the good things life has to offer. Cheers to a wonderful year ahead! 🥂
Strategic Alliance: Syngene + Cromos Pharma
Expanding Horizons: “Syngene – Cromos Pharma” Alliance Transforms Clinical Research We’re thrilled to announce our strategic alliance with Syngene! This partnership combines our expertise in offering high-quality execution and global coverage for clinical trials.  Together, we simplify patient recruitment across the US, Europe, and India, while providing comprehensive clinical development services. Superior project management ensures seamless execution of global trials and unified project updates.
Partnership Between MAIA Biotechnology and Cromos Pharma
Successful Partnership Between MAIA Biotechnology and Cromos Pharma MAIA Biotechnology and Cromos Pharma have partnered up in an innovative collaboration to advance cancer treatment. Mutual collaborative efforts are focused on THIO, a groundbreaking telomere-targeting agent for non-small cell lung cancer (NSCLC). In a trial presented at ASCO 2024, THIO demonstrated an impressive 85% disease control rate. Read more in the press release: https://www.pr.com/press-release/914337

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us